Annual report
4502.TEDINET S100W07G
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.58T | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥4.26T | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥4.03T | 2022-04-01 → 2023-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.57T | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.20T | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥342.6bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥214.1bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥175.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥52.8bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥375.1bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥302.6bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥366.2bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥107.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥144.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥317.0bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥230.1bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥376.0bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥108.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥144.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥317.0bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥230.2bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥376.2bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥14.25T | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥15.11T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥13.96T | at 2023-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥13.18T | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥12.91T | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥7.31T | at 2025-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥7.83T | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥6.94T | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥7.27T | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥6.35T | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥6.94T | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥7.27T | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥385.1bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥457.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥533.5bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥849.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥966.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥1.06T | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥716.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥977.2bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.12T | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.01T | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥367.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥463.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥607.1bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥198.1bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥393.5bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥751.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥354.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥709.1bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.07T | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.09T | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥68.36 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥92.09 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥204.29 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥147.14 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥240.72 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥67.23 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥91.16 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥201.94 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥145.87 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥238.96 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥4,407.01 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥4,635.56 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥4,087.49 | at 2023-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,665.61 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,308.93 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 48.7% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.1% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.5% | at 2023-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 43.1% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 40.1% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 1.5% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 2.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 5.3% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 4.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 7.6% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 47,455 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 49,281 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 49,095 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 47,347 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 47,099 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥580.4bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥595.6bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥632.1bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥764.3bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥602.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥36.9bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥48.1bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥86.6bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥286.4bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥340.1bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥550.9bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥50.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥199.3bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥391.3bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥152.8bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥338.9bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥330.6bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥324.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥247.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥9.49T | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥9.76T | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥9.41T | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.64T | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥10.86T | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.50T | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.67T | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.99T | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.09T | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.21T | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥4.29T | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.43T | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥169.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥130.9bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥96.79 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥216.6 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.06 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.5 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.45 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥96.78 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥216.56 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥213.05 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥207.5 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥158.44 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥196 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥188 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,534.39 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,604.87 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,704.87 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,769.31 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,835.81 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 42.0% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.8% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,590,950,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,419,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,296,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,253,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,576,388,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,808 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 5,474 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 5,486 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 5,149 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 4,966 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2025-03-31 | 47455 pure |
| Pharmaceutical Businessreportable segment | employees | at 2025-03-31 | 4808 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,774
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from sales of business net of cash and cash equivalents divested inv cf IFRS | Prior1YearDuration | 19959000000 | JPY |
| Proceeds from sales of business net of cash and cash equivalents divested inv cf IFRS | CurrentYearDuration | 20556000000 | JPY |
| Payments for the settlement of forward exchange contracts designated as net investment hedges inv cf IFRS | Prior1YearDuration | -33300000000 | JPY |
| Payments for the settlement of forward exchange contracts designated as net investment hedges inv cf IFRS | CurrentYearDuration | -13847000000 | JPY |
| Other inv cf IFRS | Prior1YearDuration | -4003000000 | JPY |
| Other inv cf IFRS | CurrentYearDuration | -1111000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YearDuration | -463862000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYearDuration | -367060000000 | JPY |
| Net increase decrease in short term borrowings and commercial paper fin cf IFRS | Prior1YearDuration | 277000000000 | JPY |
| Net increase decrease in short term borrowings and commercial paper fin cf IFRS | CurrentYearDuration | 27490000000 | JPY |
| Proceeds from issuance of bonds and long term borrowings fin cf IFRS | Prior1YearDuration | 100000000000 | JPY |
| Proceeds from issuance of bonds and long term borrowings fin cf IFRS | CurrentYearDuration | 1024460000000 | JPY |
| Redemption of bonds and repayments of long term borrowings fin cf IFRS | Prior1YearDuration | -320901000000 | JPY |
| Redemption of bonds and repayments of long term borrowings fin cf IFRS | CurrentYearDuration | -1321090000000 | JPY |
| Proceeds from the settlement of cross currency interest rate swaps related to bonds and loans fin cf IFRS | Prior1YearDuration | 60063000000 | JPY |
| Proceeds from the settlement of cross currency interest rate swaps related to bonds and loans fin cf IFRS | CurrentYearDuration | 46880000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | Prior1YearDuration | -2326000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | CurrentYearDuration | -51860000000 | JPY |
| Interest paid fin cf IFRS | Prior1YearDuration | -100375000000 | JPY |
| Interest paid fin cf IFRS | CurrentYearDuration | -112984000000 | JPY |
| Dividends paid fin cf IFRS | Prior1YearDuration | -287188000000 | JPY |
| Dividends paid fin cf IFRS | CurrentYearDuration | -302498000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YearDuration | -54586000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYearDuration | -45174000000 | JPY |
| Other fin cf IFRS | Prior1YearDuration | -26102000000 | JPY |
| Other fin cf IFRS | CurrentYearDuration | -16647000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YearDuration | -354416000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYearDuration | -751425000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | Prior1YearDuration | -101934000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | CurrentYearDuration | -61303000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 533530000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 457800000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YearDuration | 26204000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYearDuration | -11385000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 457800000000 | JPY |
| Cash and cash equivalents IFRS | CurrentYearInstant | 385113000000 | JPY |
| Change in fair value of contingent considerations income IFRS | Prior1YearDuration | － | JPY |
| Change in fair value of contingent considerations income IFRS | CurrentYearDuration | 2390000000 | JPY |
| Gain on sale of property plant and equipment IFRS | Prior1YearDuration | 144000000 | JPY |
| Gain on sale of property plant and equipment IFRS | CurrentYearDuration | 363000000 | JPY |
| Gain on sale of businesses IFRS | Prior1YearDuration | 588000000 | JPY |
| Gain on sale of businesses IFRS | CurrentYearDuration | 4117000000 | JPY |
| Gain on sale of investments in subsidiaries IFRS | Prior1YearDuration | 7243000000 | JPY |
| Gain on sale of investments in subsidiaries IFRS | CurrentYearDuration | 6081000000 | JPY |
| Other other income IFRS | Prior1YearDuration | 11404000000 | JPY |
| Other other income IFRS | CurrentYearDuration | 13262000000 | JPY |
| Other income IFRS | Prior1YearDuration | 19379000000 | JPY |
| Other income IFRS | CurrentYearDuration | 26212000000 | JPY |
| Donations IFRS | Prior1YearDuration | 7009000000 | JPY |
| Donations IFRS | CurrentYearDuration | 7663000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |